Emil Fosbøl retweeted
Congratulations to @HaversEva for successfully defending her PhD yesterday 🎊👏
With focus on
Female-Specific Risk Factors for Cardiovascular Disease ♀️ 🫀🩺
@LarsKøber
@EmilFosb
@FolkeFredrik
@Jolienroos
Emil Fosbøl retweeted
Lundbeckfondens Young Investigator Prize og Talent Prizes er netop blevet uddelt til seks talentfulde forskere fra danske hospitaler og universiteter, der gør en forskel for sundhedsvidenskaben.
Læs: lundbeckfonden.com/nyheder/p…
#talent #dkforsk #dkvid
Emil Fosbøl retweeted
First price of this years oral presentation at #DCSÅrsmøde2024 went to @KhadjiMD 🥇
We are SO honored 👏👏
Emil Fosbøl retweeted
Infective endocarditis poses diagnostic challenges. 🤔Even with newer modalities (CT/MR), echocardiography remains pivotal in managing infective endocarditis 🦠.
@JeppeKPetersen @EmilFosb
link.springer.com/article/10…
Emil Fosbøl retweeted
📅Dont forget to register for #ISCVID2024 16-18 June 🇸🇪.
This 17th symposium will be in Malmö, Sweden.
Meet top researchers and clinicians in the field of endocarditis and intravascularinfections for a high quality scientific programme!
@EmilFosb
mkon.nu/iscvid_2024
Emil Fosbøl retweeted
In this 🇩🇰 std of pts w/ #AF - all #subgroups of CHA2DS2-VASc 1️⃣ were associated w/ a ⬇️ incidence of arterial #thromboembolism compared w/CHA2DS2-VASc 2️⃣ & a ⬆️ incidence compared w/ CHA2DS2-VASc 0️⃣.
Want to know more?
Just published in @CircAHA 👇
Emil Fosbøl retweeted
We are proud to present the design and objectives of the #NIDUS registry – the first unselected contemporary nationwide infective #endocarditis (IE) registry, published in @AmericanHeartJ.
NIDUS aim is to uncover risk factors impacting the course, treatment, and outcomes of IE🦠
Så prøver jeg sgu lige det der med sociale medier.
Fra klaphat til professor🥸 @koebenhavns_uni og @Rigshospitalet har indstillet mig til professor i hjerteklapsygdom. Jeg er stolt og taknemmelig for alle de mennesker og samarbejder, der har bidraget til vores rejse. Here we go!
Emil Fosbøl retweeted
🦠9. Videnskabelige nationale møde om Infektiøs Endokarditis🦠
💥Nonbakteriel endokarditis
💥Nuklearmedicinske undersøgelser
💥POET 1 og 2
💥Farmakokinetik
💥Gentamycin
💥ENDOHOT
💥ASTERIX
📅29. marts 2023
⌚09.30–16.00
📍Aalborg Universitetshospital
cardio.dk/9-videnskabelige-n…
Emil Fosbøl retweeted
In pts undergoing #TAVR the 1-year risk of all-cause death according to comorbidity burden
🟩Low 6 %
🟦Mild 9%
🟨Median 14%
🟥High 25%
Sdy by @JarlStrange et al in @IJC_Heart_Vasc
📄sciencedirect.com/science/ar…
Emil Fosbøl retweeted
Can age and comorbidities be used to determine high-risk patients following #TAVR? 🤔
Go read this newly published paper by Dr. @JarlStrange, Dr. @EmilFosb et al. that may provide an easy-to-understand view on 1-year prognosis after #TAVR! 🫀🩺#CardioTwitter #RigsHeart
Emil Fosbøl retweeted
Vidste du, at man ikke udpumper folk, der har drukket for meget alkohol? Se Karls gode råd #sundpol #dkmedier #alkohol
Vi bruger tid & kræfter i @akutberedskabet på at tage os af folk, der har drukket for meget - og faktisk kan du hjælpe! Se Karl fortælle om det her, og del meget gerne videoen. #sundpol #dkpol @RegionH
Emil Fosbøl retweeted
🌵 JUST OUT IN @JACCJournals 🌵
Screening for cardiac amyloidosis (CA) 5-15 yrs after surgery for bilat. carpal tunnel syndrome finds approx. 5% with early-stage transthyretin CA. The clinical yield was ⏫ in non-obese👨🏼🦱>69 years. A study by Dr. @OscarWestin et al. 🫀 #RigsHeart
Emil Fosbøl retweeted
An Open Letter From @jamanetwork's Editor
"The undermining of science - and unprecedented attacks on scientists and public health officials - risks lives in every corner of our country"
@WhiteHouse @realDonaldTrump @POTUS @Mike_Pence
@NIAIDNews @NIHDirector @CDCgov @CDCDirector





















